×
ADVERTISEMENT

buprenorphine

Government Extends Telemedicine Availability of Controlled Medications

The DEA and SAMHSA extended the ability for clinicians to prescribe controlled medications without first seeing a ...

MAY 25, 2023

Buprenorphine Is Likely Safer Than Methadone for Neonates

Data from a new study indicate that treatment of pregnant women with opioid use disorder with ...

FEBRUARY 27, 2023

Nonmedical Use of Gabapentin, Opioid Agonist Medications Becomes Prevalent

Nonmedical use of gabapentin may frequently coincide with nonmedical use of methadone and buprenorphine among ...

JULY 26, 2022

Dissolvable Buprenorphine Medications Linked to Potential Dental Problems

The FDA issued a MedWatch Alert about the risk for dental problems among patients undergoing treatment with ...

JANUARY 18, 2022

Buprenorphine Misuse Decreased Among U.S. Adults With Opioid Use Disorder

Data from a nationally representative survey indicated that in 2019, nearly three-fourths of U.S. adults subscribed ...

OCTOBER 19, 2021

Pregnant Women Face Substantial Barriers To Treatment Access for OUD

A prospective study of simulated patient callers found that women with opioid use disorder experience significant ...

JANUARY 5, 2021

Medication-Assisted Treatments Underused in Patients With Opioid Use Disorder

Medication treatment of opioid use disorder after a nonfatal opioid overdose is underutilized when compared with ...

AUGUST 27, 2018

FDA Says No to Buprenorphine Spray

The New Drug Application for a new sublingual spray formulation of buprenorphine to treat moderate to severe acute ...

AUGUST 2, 2018

FDA Approves Sublocade, First Monthly Injectable Buprenorphine for Opioid Use Disorder

Buprenorphine ER should only be administered by health care providers, because serious harm or death could result ...

DECEMBER 1, 2017

Buprenorphine Final Rule Allows for Increased Access

The rule allows practitioners who have had a waiver to prescribe buprenorphine for up to 100 patients for a year or ...

JULY 19, 2016

FDA Requires Labeling Changes of MAT Drugs for Opioid Disorder in Pregnancy

Providers should weigh benefits and risks of opioids before giving to pregnant women.

JUNE 28, 2016

Load more